Overview
MDWD market data
Price History
MDWD price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$2.10 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.14 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $13.54 – $21.11 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $183.3 · P/B 5.42 · P/S 12.66.
Company news
Oppenheimer Maintains Outperform on MediWound, Lowers Price Target to $32Benzinga · May 28, 2026, 3:10 PM
HC Wainwright & Co. Reiterates Buy on MediWound, Maintains $36 Price TargetBenzinga · May 28, 2026, 12:05 PM
MediWound Reports Q1 2026 Results: Full Earnings Call TranscriptBenzinga · May 27, 2026, 1:40 PM
MediWound Affirms FY2026 Sales Guidance of $24.000M-$26.000M vs $24.759M EstBenzinga · May 27, 2026, 11:02 AM
MediWound Q1 EPS $(0.23) Beats $(0.64) Estimate, Sales $1.475M Miss $3.117M EstimateBenzinga · May 27, 2026, 11:01 AM
MediWound to Report First Quarter 2026 Financial ResultsGlobenewswire Inc · May 7, 2026, 12:10 PM